Synapse - Breast Medicine Service

Search Within

Breast Medicine Service

Results (4181)

Breast carcinoma with recurrence score lower than 18: Rate of locoregional recurrence in a large series with clinical follow-up

Meeting Abstract

Turashvili, G.; Brogi, E.; Morrow, M.; Wiszowaty, A.; Dickler, M.; Norton, L.; Hudis, C.; Wen, H. Y.
Modern Pathology (2017)

Fulltext@MSK | Save

Analysis of CDH1 in invasive lobular carcinoma (ILC): Comparison of morphology, immunohistochemistry (IHC) and mutation profile detected by hybrid capture-based next generation sequencing (NGS)

Meeting Abstract

Grabenstetter, A.; Mohanty, A. S.; Zehir, A.; Razavi, P.; Baselga, J.; Tan, L. K.; Ross, D. S.
Modern Pathology (2017)

Fulltext@MSK | Save

Breast carcinoma with 21-gene recurrence score lower than 18: Rate of distant metastases in a large series with clinical follow-up

Meeting Abstract

Wen, H. Y.; Krystel-Whittemore, M.; Patil, S.; Pareja, F.; Bowser, Z. L.; Dickler, M.; Norton, L.; Morrow, M.; Hudis, C.; Brogi, E.
Cancer Research (2017)

Fulltext@MSK | Save

Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer

Meeting Abstract

Nangia, J. R.; Wang, T.; Niravath, P. A.; Otte, K.; Osborne, C. R.; Papish, S.; Holmes, F. A.; Abraham, J.; Goldfarb, S.; Courtright, J. G.; more...
Cancer Research (2017)

Fulltext@MSK | Save

Primary analysis of BERENICE: A phase II cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with locally advanced, inflammatory, or early-stage, unilateral, and invasive HER2-positive breast cancer

Meeting Abstract

Swain, S. M.; Ewer, M. S.; Viale, G.; Delaloge, S.; Ferrero, J. M.; Verrill, M.; Colomer, R.; Vieira, C.; Werner, T. L.; Douthwaite, H.; more...
Cancer Research (2017)

Fulltext@MSK | Save

Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer

Meeting Abstract

Tanioka, M.; Fan, C.; Carey, L. A.; Hyslop, T.; Pitcher, B. N.; Parker, J. A.; Hoadley, K. A.; Henry, N. L.; Tolaney, S.; Dang, C.; more...
Cancer Research (2017)

Fulltext@MSK | Save

Phase 3 study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer who have stable brain metastases previously treated with an anthracycline, a taxane, and capecitabine

Meeting Abstract

Tripathy, D.; Tolaney, S.; Seidman, A. D.; Anders, C. K.; Ibrahim, N.; Rugo, H. S.; Twelves, C. J.; Cortes, J.
Cancer Research (2017)

Fulltext@MSK | Save

Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy

Meeting Abstract

Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
Cancer Research (2017)

Fulltext@MSK | Save

A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)

Meeting Abstract

McArthur, H. L.; Beal, K.; Halpenny, D.; Henrich, M.; Patil, S.; Young, R.; Kaley, T.; Hamilton, N.; Hudis, C.; Wolchok, J.; more...
Cancer Research (2017)

Fulltext@MSK | Save

Oncologic outcome of pregnancy associated breast cancer: A case-control study

Meeting Abstract

McCartan, D.; Kamer, S.; Eaton, A.; Seidman, A.; Murphy, C.; Gemignani, M.; Goldfarb, S.
Cancer Research (2017)

Fulltext@MSK | Save